Global Webcast – 30 May

Register for the World MS Day webcast: Improving MS Diagnosis Globally

Early diagnosis of multiple sclerosis (MS) is vital to enable early treatment and reduce future disability. Yet the MS community face barriers preventing early diagnosis in 83% of countries worldwide.

This World MS Day (30 May 2025), we’re calling for action. Join the World MS Day webcast Improving MS Diagnosis Globally as we explore global solutions with real case studies. The webcast unpacks key findings from the Brain Health – Time Matters report and how these can be applied to improve MS diagnosis. Hear from an international panel featuring people with MS, experts in neurology and MS research, and MS organisations leading innovative diagnosis work.

What you’ll learn about:

• Why timely and accurate MS diagnosis is critical
• Key diagnosis recommendations from the Brain Health – Time Matters report
• How different MS organisations around the world are driving change

This one-hour webcast is open to everyone—people living with MS, advocates, healthcare professionals, and anyone passionate about improving MS care.

Date: 30 May – World MS Day

Platform: Streamed on World MS Day Facebook and YouTube channels

Duration: 1 hour

Time: 13:00 BST (London), 14:00 CEST (Berlin), 08:00 EDT (New York), 06:00 CST (Mexico City), 17:30 IST (New Delhi), 20:00 CST (Beijing), and 22:00 AEST (Sydney).

Register below to ensure access to the webcast post-event if you are unable to join live.

World MS Day is supported by grants from Coloplast, Merck, Novartis, Roche and Sanofi. The campaign is operated independently and our grant makers have no editorial control over its contents. To understand how we work with the Healthcare Industry, please visit the MSIF website.

Webcast Panel

Host

Angela White has been a leader in the MS movement since her diagnosis of multiple sclerosis in 2002. As volunteer for the National MS Society, U.S., she has advocated for needed change in public policy, served as a committee member of the Black MS Experience Summit and reviewed MS research applications. She also is engaged in the MS International Federation’s Patient Reported Outcomes Initiative. Angela is certified as a group fitness instructor and as a specialist in fitness nutrition. She is currently laying the groundwork to offer classes for people living with mobility and neurological challenges, both locally and virtually.

Panelists

Professor Gavin Giovannoni is a neurologist based in London, UK. His current research and clinical interests are focused on multiple sclerosis (MS). Gavin Giovannoni was appointed to the Chair of Neurology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London in November 2006. His clinical interests are multiple sclerosis and other inflammatory disorders of the central nervous system. He has recently become the co-director of the Preventive Neurology Unit, Wolfson Institute of Population Health.

Anne Helme, PhD is Head of Research and Access at the Multiple Sclerosis International Federation (MSIF), based in London, UK. In this role, she has oversight of MSIF’s participation in global research collaborations, such as the Progressive MS Alliance and the global Patient Reported Outcomes for MS Initiative. In terms of access to healthcare, she works closely with colleagues leading global projects addressing challenges in access to disease-modifying therapies. She believes that globally accessible, comparative data on MS is crucial for advocacy efforts to improve MS healthcare, and is interested in how the development of national registries and MSIF’s Atlas of MS can support this. Anne has a PhD in Zoology, and has previously held research, communications and education roles at scientific and medical charities in the UK.

Kanya Puspokusumo is the Founder and President of the Yayasan Multipel Sklerosis Indonesia (The Indonesian Multiple Sclerosis Foundation) established in 2008. Diagnosed with Relapsing-Remitting MS in 2001 in Japan, she has since become a global advocate for people with chronic illnesses. From 2009 to 2011, she served as a Board Member of MSIF. She has over 30 years of experience as a language educator, translator, and writer. Her works include Brave Like Me (a children’s e-book for those with chronic/invisible illness), and her memoir My Story Isn’t Over Yet.  Kanya continues to inspire through education, storytelling, and international advocacy.

Professor Anu Jacob is the Director of Multiple Sclerosis and Autoimmune Neurology at Cleveland Clinic Abu Dhabi from 2020. Dr. Jacob completed his neurology training in India and UK and his Multiple Sclerosis fellowship at Mayo Clinic, Rochester, Minnesota.   Prior to joining Cleveland Clinic Abu Dhabi, Dr. Jacob was a consultant neurologist in Liverpool, United Kingdom.   Dr. Jacob was the Director for Multiple Sclerosis services for North Wales, and founder director for the United Kingdom NHS specialist service for Neuromyelitis optica. He has authored more than 140 peer reviewed research articles and is the   Lead author for UAE MS DMT guidelines 2024

Beatriz Martínez de la Cruz has been the CEO of MS Society Spain: “Esclerosis Múltiple España” since March 2023. With 25 years of experience within the pharmaceutical Industry and Non-Profit Organizations in different areas: Corporate and Public Affairs, Marketing and Health Communication, Customer Engagement with KOLs, Medical and Scientific Societies, Patient Advocacy, Patient Experience and engagement, Customer Medical Education, Clinical Operations Management.